Biotech Innovation Cycle and Technological Advancement
IBB iShares Biotechnology ETF
$207.74 -0.86%
View chart & analysis → - 1Moderna recorded a 587% increase compared to the beginning of the year.
- 2There are approximately 12 new biological products approved by the FDA in 2025.
- 3Biopharma transaction volume reached $134 billion in the first half of 2026.
So what's the key point?
Moderna has risen by 587% since the start of this year. The biotech sector is becoming more active as the scale of transactions among biotech companies grows.
Source CNBC · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.